News

We are proud to announce that Dr. Keyue Sun and the Schlegel Lab have been selected as the...

NADMED has partnered with London-based Altheome Labs to expand access to advanced NAD testing in...

A new abstract, presented at the American Stroke Association’s Conference, explores how NAD and...

A study in Cell Reports Medicine shows significantly lower NAD+ levels in the brains of...

A newly published study reveals that NAD⁺ can restore memory in Alzheimer’s disease models by...

NADMED has been selected to join the prestigious AMPlify program, a U.S. market entry initiative...

Affinity Biomarker Labs, based in London, UK, is the latest partner to join the NADMED network,...

Research and Markets, one of the world’s leading market research firms, has identified NADMED as...

The investment round was led by Finnish science-based startup investor Nordic Science Investments...

A study involving a healthy population of 1162 individuals revealed that persistent high niacin...

In a recent study, researchers found that high NAD(H)+ amounts slow down the growth of highly...

Full NADMED REDOX profiling was used in a Norwegian study to contribute to Parkinson’s research....

Exposure to cold is known to cause changes in NAD+ precursors which are associated with brown...

NADMED method has been used to detect NAD levels in muscle myopathy study conducted by several...

NADMED attends this year's Ending Age Related Diseases summit in New York 10-11th August. If you...

NADMED is one of ten companies chosen for the Deep Tech Accelerator Funding program. The companies...

NADMED attends the premier international conference on mitochondrial disease EUROMIT 11-15 June....

A recent study with mice suggests NAD+ repletion with niacin counteracts cancer cachexia. The...

Doctors in the U.S. can now access a novel NAD blood diagnostic for their patients. TruDiagnostic...

A recently published study in Science Advances shows benefits of long-term NR supplementation, but...

NADMED technology was used in a clinical case study about an adult patient diagnosed with NADSYN1...

NADMED was invited to the San Francisco Longevity Summit 2022, one of North America's most...

NADMED is attending this year's Slush event 17.-18.11. with the University of Helsinki. You can...

NADMED was chosen among the best clinical laboratory services in Europe. The selection was made by...

The easy and reliable method that measures all NAD metabolites has also convinced financiers....

NADMED raised a lot of interest among the VC investors at Nordic Life Science days 2022 in Malmö,...

Leaders in the aging and longevity field are gathered in the 9th Aging Research and Drug Discovery...

NADMED's new website was published in the end of June 2022. Designers' goal was to build a...

NADMED's board is full of excellence. The new board members are Juha Tuominen, former CEO of HUS,...

NADMED was chosen for the Health Incubator Helsinki's startup program among eight other life...